Impact of a COPD Discharge Care Bundle on Readmissions following Admission with Acute Exacerbation: Interrupted Time Series Analysis. by Laverty, AA et al.
RESEARCH ARTICLE
Impact of a COPD Discharge Care Bundle on
Readmissions following Admission with Acute
Exacerbation: Interrupted Time Series
Analysis
Anthony A. Laverty1*, Sarah L. Elkin2, Hilary C. Watt1, Christopher Millett1, Louise
J. Restrick3, SianWilliams3, Derek Bell4, Nicholas S. Hopkinson5
1 Department of Primary Care and Public Health, Imperial College London, London, England, 2 Imperial
College London NHS Trust, London, England, 3 London Respiratory Team NHS London, London, England,
4 NIHR CLAHRC for Northwest London, London, England, 5 NIHR Respiratory Biomedical Research Unit at
Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, England
* a.laverty@imperial.ac.uk
Abstract
Objectives
We evaluated the impact of a COPD discharge care bundle on readmission rates following
hospitalisation with an acute exacerbation.
Design
Interrupted time series analysis, comparing readmission rates for COPD exacerbations at
nine trusts that introduced the bundle, to two comparison groups; (1) other NHS trusts in
London and (2) all other NHS trusts in England. Care bundles were implemented at different
times for different NHS trusts, ranging from October 2009 to April 2011.
Setting
Nine NHS acute trusts in the London, England.
Participants
Patients aged 45 years and older admitted to an NHS acute hospital in England for acute
exacerbation of COPD. Data come from Hospital Episode Statistics, April 2002 to March
2012.
Main OutcomeMeasures
Annual trend readmission rates (and in total bed days) within 7, 28 and 90 days, before and
after implementation.
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Results
In hospitals introducing the bundle readmission rates were rising before implementation
and falling afterwards (e.g. readmissions within 28 days +2.13% per annum (pa) pre and
-5.32% pa post (p for difference in trends = 0.012)). Following implementation, readmission
rates within 7 and 28 day were falling faster than among other trusts in London, although
this was not statistically significant (e.g. readmissions within 28 days -4.6% pa vs. -3.2% pa,
p = 0.44). Comparisons with a national control group were similar.
Conclusions
The COPD discharge care bundle appeared to be associated with a reduction in readmis-
sion rate among hospitals using it. The significance of this is unclear because of changes to
background trends in London and nationally.
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a common condition, estimated to affect
1.4 million people in England alone [1] and is now the 3rd most common cause of death world-
wide[2]. The primary cause of COPD is tobacco smoking and 86% of deaths from COPD are
attributable to smoking [3] Acute exacerbations of COPD (AECOPD) are the second most
common cause of emergency hospital admission in the UK [3] and a frequent cause of admis-
sion with breathlessness. Outcomes are poor with around one third of patients readmitted to
hospital within 90 days and an overall 90 day mortality rate of 13.9% [4,5].
There is also considerable variability in outcomes, with 90- day readmission rates ranging
between 16% and 48% in the latest European Respiratory Society audit, and ten-fold variation
in 90 day[6]. Care bundles have been proposed as an effective approach to improve the quality
of patient care. Care bundles are made up of a short series of evidence-based interventions that
should be delivered for all patients with a condition, irrespective of ward, or specialty, deliver-
ing care. Care bundles have been used in a variety of conditions with effectiveness demonstrat-
ed in a range of settings[7–9].
In London, which has a population of 8 million (comparable in size to a number of coun-
tries) and a 2008 smoking prevalence of 19%, £100m was spent on COPD care, with more than
90,000 beds used for emergency hospital admissions for patients with a primary diagnosis of
COPD in 2008–9 [10]. This unmet patient need, significant use of urgent care and unwarranted
variation led to the design and initial implementation of a COPD discharge care bundle by the
NIHR CLAHRC for Northwest London which has been described previously [8,11].
The care bundle recommendations are that all patients admitted with an AECOPD receive
the following interventions from staff who have the appropriate competencies, most often de-
livered by one or more clinicians who are members of a respiratory team; (1) Evidence-based
smoking cessation interventions (support and pharmacotherapy) and offer of referral to smok-
ing cessation service if a current smoker; (2) Assessment for, explanation of, and referral to, a
pulmonary rehabilitation programme; (3) Appropriate education, written personalised infor-
mation including information about patient support groups (British Lung Foundation (BLF)
Breathe Easy Groups), self-management plans (for example, BLF self-management booklet),
and, if appropriate, rescue packs for future exacerbations and an oxygen alert card or equiva-
lent; (4) Assessment of patient understanding and use of medications with focus on enabling
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effective inhaler technique; (5) Leave hospital with booked review once discharged from hospi-
tal. Care bundles aim both to improve quality of care, and to standardise delivery, so that all of
the included elements are delivered routinely.
The Northwest London COPD Discharge Bundle was endorsed for use across London by
the London Respiratory Team, on behalf of the NHS in London, in 2010 and a Commissioning
for Quality and Innovation (CQIN) payment framework to support implementation of the
COPD discharge bundle by acute trusts was made available for use by commissioners from
2011[10,12]. As a result the bundle was rolled out in a number of acute hospitals in London,
incentivised in some by commissioners using the CQIN.
This study aimed to evaluate the impact of implementing the care bundle on readmissions
for AECOPD and number of bed days occupied at hospitals using the care bundle. Outcomes
for hospitals implementing the care bundle were assessed relative to two comparison groups
(1) other NHS trusts in London and (2) all other NHS trusts in England.
Methods
The care bundle was developed at Chelsea andWestminster NHS Foundation Trust, based on
national and international guidelines, and input was sought from the Inner Northwest London
Care Community integrated service improvement programme for COPD[8]. After piloting on
a respiratory ward at Chelsea and Westminster it was rolled out to three other trusts between
April and September 2010. In April 2011, the COPD care bundle was added as a CQUIN for a
further five NHS trusts in London (see Table 1).
Data
Data for this study come from Hospital Episode Statistics (HES) which is the national adminis-
trative database for hospital activity in England. HES contains information on all admissions to
the National Health Service (NHS), and includes clinical information on diagnoses of patients
as well as demographic information and the speciality under which they were treated [13].
Data on all COPD admissions to NHS acute trusts utilising the bundle from 1st April 2002 to
31st March 2012 were used. Patients aged 45 years and above were included. All data were ana-
lysed at the monthly level, although annualised trends are presented for ease of interpretation.
This research was based on the use of anonymous secondary data. The Department of Primary
Table 1. Implementation dates of COPD care bundle.
Trust name Implementation date
Chelsea and Westminster NHS Foundation Trust October 2009
Imperial College Healthcare NHS Trust April 2010
West Middlesex University Hospital NHS Trust May 2010
The North West London Hospitals NHS Trust September 2010
Epsom and St Helier University Hospitals NHS Trust April 2011
Kingston Hospital NHS Foundation Trust April 2011
Mayday Healthcare NHS Trust* April 2011
St Georges Healthcare NHS Trust April 2011
The Whittington Hospital NHS Trust** April 2011
* Subsequently changed to Croydon Health Services NHS Trust
** Merged to become Whittington Health from April 2011
doi:10.1371/journal.pone.0116187.t001
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Care & Public Health has approval from the Health and Social Care Information Centre to use
this data for health service evaluation.
Outcome measures
An acute exacerbation of COPD was defined as any patient admitted to hospital as an emer-
gency (admimeth>21 &<29) with the ICD-10 codes “J440” or “J441” as their primary reason
for admission.
Readmissions among COPD patients were defined as readmission for acute exacerbation of
COPD to any of the NHS trusts in the study, within 7, 28 or 90 days of their discharge after an
original admission for an acute exacerbation of COPD. The last month of the data series was
not used in the analysis of 28 day readmission rates as these could not be calculated, and the
last three months were not used for readmission within 90 days. The total number of bed days
was calculated by summing the number of nights in hospital for all patients with COPD,
whether an original admission or a readmission.
Analysis
We used an interrupted time series (ITS) approach analysing readmission rates (with Poisson
regression using number of admissions as the exposure). The analysis was clustered at the trust
level. Time was standardised to time of introduction of the bundle in each trust, to allow for
the overall impact of the bundle to be evaluated. In non-bundle trusts, we examined trends on
a date when most trusts introduced the bundle, which was October 2009. ITS approaches are
considered to be the strongest quasi-experimental approach for evaluating interventions where
randomisation isn’t feasible [14] and allow us to estimate separate trends for both intervention
and comparison groups both before and after care bundle implementation. Use of ITS allowed
examination of differences in COPD readmission trends post intervention, allowing for any
trends before its introduction, and including allowing for changes in trends in the control
group (i.e. effectively a difference in difference approach). We did not include a term for a step
change on introduction of the bundle, as in practice implementation of the bundle was gradual,
starting from the date specified. These models are adjusted for the age and sex profile of admit-
ted patients, as well as the month of admission (to take account of seasonal effects) and depri-
vation level of admitted patients. Deprivation was measured using the Index of Multiple
Deprivation (IMD) on the home postcodes of individual patients and divided into thirds based
on the national distribution of deprivation ranks. Analysis of bed days used the same model
form with linear rather than Poisson regression. All analyses were conducted using Stata ver-
sion 12.0.
Results
Analyses of trends in outcomes before and after bundle implementation among trusts which
were using the bundle by 2011–12 are shown in Table 2. Trusts using the bundle had a mean of
209.1 7-day COPD readmissions annually (standard deviation (SD) 59.4), and 562.8 (144.9)
28-day readmissions annually. Prior to implementation of the bundle, 7, 28 and 90 day read-
missions were rising (e.g. +2.13% for 28-day readmissions) as were number of COPD bed days
(+263.7 bed days annually). After implementation of the bundle, all four of these outcomes
were declining (e.g. -5.32% pa for 28-day readmissions, p for difference = 0.012).
Results from the ITS analysis comparing bundle trusts to other trusts in London are shown
in Table 3. Prior to bundle implementation 7, 28 and 90 day readmissions were rising in both
the London comparison group and the bundle trusts. For example, 28-day readmissions were
rising at +2.2% per year among bundle trusts compared to +1.3% among other London trusts
Impact of COPDDischarge Care Bundle
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(p for difference = 0.279). After implementation of the bundle readmissions were coming
down among both groups—for 28-day readmissions at-4.6% pa among bundle trusts and-3.2%
at London comparison trusts, p for difference (adjusted for baseline) = 0.440. Numbers of bed
days were coming down slowly among both groups, before and after implementation of the
bundle. Table 3 also shows the effect sizes which would be needed to achieve statistical signifi-
cance of the care bundle giving the prevailing trends at other London trusts. This shows that
given the-3.2% decrease in the rest of London after bundle implementation, the bundle would
have had to affect a decrease of 11.7% to be statistically significant at p0.05. Fig. 1 gives a
graphical representation of the raw data for 28 day readmissions for the bundle trusts as well as
the London comparison group. This allows examination of both the variation in the outcome
over time and also the lack of clarity over whether the trend for the bundle trusts is different to
that for the comparison group.
Results from the ITS analysis comparing bundle trusts to other NHS acute trusts nationally
are shown in Table 4. Prior to bundle implementation 7, 28 and 90 day readmissions were ris-
ing in both the London comparison group and the bundle trusts, and these rises were faster
among bundle trusts than the national comparison group. For example, 28-day readmissions
were rising at +2.5% per year among bundle trusts compared to +0.7% among other London
trusts (p for difference = 0.012). After implementation of the bundle 7-day readmissions were
coming down among both groups at-2.5% pa for the national group and-7.4% pa for the bun-
dle group, p for difference = 0.213. 28 and 90-day readmissions continued to rise among the
Table 2. Pre/post analysis for bundle trusts.
7 day readmissions 28 day readmissions 90 day readmissions Number of bed-days
Mean annual number (SD), 2002–2012 209.1 (59.4) 562.8 (144.9) 1,014 (243.2) 27,769.4 (3,419.4)
Annual trend in COPD admissions pre October 20091 +2.7% (0.019) +2.1% (0.002) +1.4% (0.007) -0.8 (<0.001)
Annual trend in COPD admissions post October 20092 -7.6% (0.028) -5.3% (0.012) -1.3% (0.267) -1.6 (<0.001)
1 P-value refers to difference of this trend from zero
2 P-values refer to difference between this trend and pre-implementation trend
doi:10.1371/journal.pone.0116187.t002
Table 3. Bundle trusts vs. other London trusts for COPD admissions.
7 day
readmissions
28 day
readmissions
90 day
readmissions
Number of bed-
days
Mean annual number for London COPD admissions, 2002–
2012
345.3 (49.0) 1,008.4 (141.8) 1,841.6 (207.8) 46,404 (8,130.7)
Mean annual number for bundle COPD admissions, 2002–
2012
209.1 (59.4) 562.8 (144.9) 1,014 (243.2) 27,769.4 (3,419.4)
Annual trend in London readmissions pre-implementation 1 +1.8% (0.042) +1.3% (0.008) +0.7% (0.053) -1.3 (<0.001)
Annual trend in bundle readmissions pre-implementation 2 +3.0% (0.394) +2.2% (0.279) +1.4% (0.261) -2.1 (<0.001)
Annual trend in London readmissions post-implementation 2 -4.0% (0.100) -3.2% (0.035) -1.9% (0.135) -2.8 (0.038)
Annual trend in bundle readmissions post-implementation 3 -7.3% (0.355) -4.6% (0.440) -0.8% (0.884) -3.6 (0.718)
Effect size would need for p≤0.05 -15.5% -11.7% -10.5% -8.6
1 P-value refers to difference of this trend from zero
2 P-values refer to difference between these trends and the trend in London comparison trusts
3 P-value refers to difference between this trend and trend in London comparison trusts, adjusted for baseline trends
doi:10.1371/journal.pone.0116187.t003
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Fig 1. 28 day readmissions in bundle trusts and London comparison group.
doi:10.1371/journal.pone.0116187.g001
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national comparison group after implementation of the bundle, while these fell for trusts using
the bundle. For example, 28-day readmissions +0.41% pa among the national comparison
group vs. -4.05% for the bundle group, p for difference = 0.087. After implementation of the
bundle, bed days in the bundle group were coming down more quickly than the national com-
parison group (-1.2 vs. -2.0, p for difference = 0.045). As with the comparison to London, the
effect sizes required for statistical significance are large—e.g. 28-day readmission rates would
have to have been falling by 4.5%pa to identify an effect against the background change. Fig. 2
gives a graphical representation of the raw data for 28 day readmissions for the bundle trusts as
well as the national comparison group.
S1 to S3 Tables include the results from analyses using a wider definition of COPD of ICD-
10 codes J40–44.
Discussion
Main findings
The main finding of this study is that the implementation of the COPD discharge care bundle
during hospital admission was associated with a change from an upwards trend in readmission
rates for patients with COPD to a downwards one. This change however, was not found to be
statistically significantly different to either a London or a national comparison group. Due to
the small number of NHS trusts using the care bundle and the short time since implementa-
tion, large effects on readmission rates would have been needed in order to more confidently
assert a positive impact on readmission rates. It is also possible that other work to improve the
quality of care in COPD, including systematic approaches to the delivery of the five interven-
tions in the COPD bundle, either individually or as a bundle, in other trusts across London and
nationally over this time masked the impact of introducing the bundle [15]. Unfortunately in-
formation on these interventions at other trusts was not available for this analysis. The COPD
discharge care bundle is recognised by clinicians and commissioners [10,16] as a means to sys-
tematise the implementation of high value [17], evidence-based items of care for patients ad-
mitted to hospital with COPD which may have a positive impact on readmissions, although
further research is still required.
Table 4. Bundle trusts vs. other trusts nationally for COPD admissions.
7 day
readmissions
28 day
readmissions
90 day
readmissions
Number of bed-
days
Mean annual number for national trusts COPD admissions,
2002–2012
3,947.7 (470.1) 11,398.3 (1,189.8) 20,614.9 (2,543.5) 563,526.3
(61,460.4)
Mean annual number for bundle COPD admissions, 2002–
2012
209.1 (59.4) 562.8 (144.9) 1,014 (243.2) 27,769.4 (3,419.4)
Annual trend in national readmissions pre-implementation 1 +1.4% (<0.001) +0.7% (<0.001) +0.3% (0.011) -1.0 (0.001)
Annual trend in bundle readmissions pre-implementation 2 +3.2% (0.126) +2.5% (0.012) +1.6% (0.013) -0.8 (0.029)
Annual trend in national readmissions post-implementation 2 -2.5% (<0.001) +0.4% (0.001) +1.0% (0.246) -1.2 (0.001)
Annual trend in bundle readmissions post-implementation 3 -7.4% (0.213) -4.1% (0.087) -0.9% (0.397) -2.0 (0.045)
Effect size would need for p≤0.05 -11.7% -4.5% -1.8% N/A
1 P-value refers to difference of this trend from zero
2 P-values refer to difference between these trends and the trend in national comparison trusts
3 P-value refers to difference between this trend and trend in national comparison trusts, adjusted for baseline trends
doi:10.1371/journal.pone.0116187.t004
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Fig 2. 28 day readmissions in bundle trusts and national comparison group.
doi:10.1371/journal.pone.0116187.g002
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Significance of the findings
As far as we are aware, this is the first evaluation of the impact of implementation of a COPD
discharge care bundle across a number of hospitals in England. The present study develops
from our previous work showing a trend towards a decline in hospital COPD readmission
rates after the bundle had been implemented on a single respiratory ward [8]. The bundle has
been in place for a relatively short period of time so these results may change with more data
points. In 5 trusts, implementing the care bundle as part of a CQIN, only 12 months data were
available and longer term evaluation would be useful. The advantage of using a CQIN is that it
is an enabler for care bundle interventions to be delivered for every patient admitted with
AECOPD. This is important in order to reduce unwarranted variation as only 53% of patients
admitted with COPD were under the care of a respiratory team at discharge in the last national
COPD audit[18]. The CQIN targets set for these hospitals were based on percentage use for all
patients admitted for more than 48 hours, whether on a respiratory ward, an acute admissions
ward or another medical ward (increasing from 70% to 95% according to local negotiations).
The care bundle approach is helpful in focusing attention on the highest value interventions
in COPD care, in particular support and medication to stop smoking and pulmonary rehabili-
tation, and to highlight deficiencies in the provision of care [17]. Despite the evidence for quit
smoking interventions as a very high value treatment in COPD [11], the evidence that for
every 1% increase in smoking prevalence in the COPD population there is a 1% increase in ad-
mission rates for COPD [19], smoking prevalence in patients admitted to hospital with COPD
in England in 2008 was 33%[18]. In the UK, many areas still have limited and only some or no
provision of pulmonary rehabilitation for patients with COPD[20,21], including some areas in
London. This is despite a Grade A evidence base for pulmonary rehabilitation for people who
are breathless due to COPD and clinical guidelines that reflect this [22–24] including meta-
analysis suggesting that post exacerbation pulmonary rehabilitation has an estimated number
needed to treat of four to prevent one readmission [25]. The institution of a care bundle brings
these unmet population needs into focus and may help to guide commissioning. The British
Thoracic Society are currently trialling a version of the care bundle, including additional ele-
ments when patients are admitted to hospital, such as ensuring a correct diagnosis of COPD
[11,26]. Results from this evaluation are likely to impact on use of care bundles. Research on
implementation of the bundle has concluded that successful implementation relied on an
awareness of the likely challenges of implementation, which include a lack of staff engagement,
issues of clinical coding and the added workload of the bundle for frontline staff [11].
A recent audit of admissions with AECOPD found there to be wide variability in adherence
to quality standards across Europe[6], and these results suggest that using a care bundle may
be an effective method of standardising and improving care. Hospital admission is only one of
a number of opportunities and locations to deliver high value COPD care and a population
based approach, including locally enhanced services for COPD, has also been shown to have a
significant impact on patient care [27,28] particularly when part of a shared approach across
the whole pathway[29].
Methodological issues
This study has the weaknesses inherent in using routine data for evaluation. Due to the short
period of time since bundle implementation and the small number of trusts using the bundle,
estimation of post-intervention trends was subject to random measurement error. This means
that very large effects would have to be associated with the bundle in order to be found to be
statistically significant with this data. Other weaknesses also include concerns over the accuracy
of clinical coding (upon which case ascertainment was based), although evaluation of coding
Impact of COPDDischarge Care Bundle
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by the Audit Commission have found it to be valid [30]. Sensitivity analyses using a wider defi-
nition of diagnostic codes for COPD gave similar results. We limited inclusion to patients with
ICD-10 codes for an acute exacerbation of COPD, and it is likely that some patients admitted
with COPD were not picked up using these specific codes.
Our analysis only included patients with a primary diagnosis of COPD (considered as the
reason for admission) in the COPD group. This was because patients with secondary diagnoses
of COPD are likely to have been admitted to hospital for reasons other than COPD, and out-
side the scope of the care bundle. It is difficult to ascertain whether COPD may have contribut-
ed to their hospital admission, or whether it was coded as a pre-existing condition only.
However, this does not take account of the group of patients admitted with pneumonia who
have COPD where their underlying COPD is directly contributory.
We did not include a measure of the number or extent of comorbid conditions which pa-
tients may have had, and have only controlled for their age, sex and deprivation level. There
are two reasons for this. Firstly, the population develops increasing comorbidities over time, so
adjusting for this would be likely to make the effect of the bundle more positive. Secondly,
many of the comorbidities at a patient level should already be picked up by controlling for age,
sex and deprivation. The approach we have taken is therefore a more conservative estimation
of the effect of the care bundle. However, it is well recognised that for patients with COPD only
a proportion of readmissions are with an AECOPD and evaluating the impact of interventions
in one disease domain may be less useful in the longer term than evaluating impact on any re-
admissions and total bed-days over a year.
We compared COPD patient readmission rates among trusts using the care bundle to two
comparison groups which were not to our knowledge using care bundles systematically for
COPD. During the time course of the study other changes may have influenced readmission
rates including changes in community care or quality of primary care. Additionally, data
was not available for this study on whether some patients were offered only part of the pack-
age of measures in the bundle, or what take-up of interventions such as pulmonary rehabilita-
tion was. This study focused on readmissions to hospital, rather than other measures,
such as mortality, which have been criticised as being too variable to be a useful metric of
quality of care [4]. As a strategy designed to systematise the delivery of evidence based
interventions other measures of patient experience may be more sensitive and could be con-
sidered for future study. Further work could also examine the cost-to-benefits of using such
care bundles.
Conclusion
The COPD discharge care bundle appeared to be associated with a reduction in readmission
rate among hospitals using it. Caution is needed in evaluating this however given a background
downward trend in readmission rates in London and nationally which make determining the
effect of the care bundle intervention more difficult.
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